Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharmaceuticals Share News (FARN)

Share Price Information for Faron Pharmaceuticals (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 93.00
Bid: 91.00
Ask: 95.00
Change: -1.00 (-1.04%)
Spread: 4.00 (4.396%)
Open: 96.00
High: 96.00
Low: 93.00
Prev. Close: 96.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Joules nomad resigns; Pharma C loss narrows

Fri, 18th Nov 2022 19:49

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Joules Group - Leicestershire, England-based country lifestyle retailer - Peel Hunt LLP resigns as nominated adviser and broker with immediate effect. If replacement nominated adviser is not appointed within a month, admission of company's share to trading on AIM will be cancelled. Says "has no current intention of appointing a replacement nominated adviser". Joules on Wednesday named Interpath Ltd as administrators.

----------

Upland Resources Ltd - London-based oil and gas company - Says wholly owned subsidiaries UPL Saouaf Ltd and Upland N Tunisia Ltd give Nobel Petroleum USA Inc and Pennpetro Energy PLC seven days notice for termination of farm-out agreement. Says long stop date has passed without certain conditions contained in the agreement being fulfilled. Agreement allowed NPUSA to farm-in into Upland's Saouaf permit area in Tunisia. UPL Saouaf says application to renew Saouaf permit "under consideration".

----------

Pharma C Investments PLC - New Jersey-based early-stage investor in the medical cannabis industry - Pretax loss narrows to GBP124,000 in the six months to June 30 from GBP247,000 in the same period last year. Company recorded no revenue. Has GBP275,000 investment in Product Earth, made in November 2021. Says Product Earth has "significant growth potential" and can "consolidate its position as the leading UK-based marketing growth engine for the legal cannabis and related plant wellness industries." Chair Sharon Segal says "the directors believe that the market sector which the company is focused upon investing in is growing and will be of increasing importance and that the company is well placed to identify the right opportunities to explore."

----------

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical-stage biopharmaceutical company - Amends warrants agreements with IPF Partners. The warrant price will now be the lower of EUR1.85 per share or price of any subscription fundraise undertaken by the company.

----------

By Chris Dorrell; chrisdorrell@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
24 Oct 2016 08:33

Faron Begins Recruitment For Japanese Phase 3 Traumakine Trial

Read more
21 Sep 2016 15:13

Faron Pharma raises £8m to fund R&D

(ShareCast News) - AIM listed Faron Pharmaceuticals raised £8m through a share placing and subscription to fund safety trials, pre-clinical advances and various research and development operations in biopharmaceuticals. The Finland-based company raised £8m through a placing of about 2.86m shares and

Read more
13 Jun 2016 08:18

Faron Pharmaceuticals Inks Licensing Deal For Traumakine In Korea

Read more
26 May 2016 09:19

Faron Pharmaceuticals Expands Development Strategy For Clevegen

Read more
3 May 2016 08:24

Faron Pharmaceuticals Appoints Medical Director Amid Expansion

Read more
19 Apr 2016 08:03

Faron Pharmaceuticals Files Two Finnish Patents For Clevegen

Read more
10 Mar 2016 10:20

Faron Pharmaceuticals Loss Widens On London Listing And R&D Costs

Read more
1 Mar 2016 09:29

Faron Pharmaceuticals Files Traumakine Patent Application In Finland

Read more
1 Mar 2016 09:29

Faron Pharmaceuticals Files Traumakine Patent Application In Finland

Read more
7 Jan 2016 08:02

Faron Gets Good Results From Japanese Traumakine Trials

Read more
29 Dec 2015 07:48

Faron Pharmaceuticals Recruits First Patient For Traumakine Trial

Read more
21 Dec 2015 12:55

Faron Pharmaceuticals Gets EUR1.5 Million Funding For Clevegen

Read more
30 Nov 2015 09:35

Faron Pharmaceuticals Notes Study Supporting Clevegen Programme

Read more
17 Nov 2015 12:02

Sealand Capital, Faron Pharmaceuticals Up After Market Debuts (ALLIPO)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.